RAKIN KEVIN — SEC insider filings
SEC reporting owner CIK 1184421. 39 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers all 39 filings on record, filed 2020-10-13 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 8 legs across 7 filings — 4,966,039 shares, $13,891,433 total (shares × price as filed on priced legs).
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 120,100 shares, $728,160 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 56.
- Largest priced transaction: purchase of 441,176 shares @ $17.00 ($7,499,992) in ELUTIA INC., filed 2020-10-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ELUTIA INC. (ELUT) | Director, 10% owner | 21 | 8 legs · 4,966,039 sh · $13,891,433 | — | 26 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | Director | 10 | — | 2 legs · 31,100 sh · $536,926 | 22 |
| Quantum-Si Inc (QSI) | Director | 8 | — | 1 leg · 89,000 sh · $191,234 | 8 |
Insider filings — RAKIN KEVIN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | ELUTIA INC. (ELUT) | Grant/award (A): 176,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | ELUTIA INC. (ELUT) | Grant/award (A): 159,590 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | ELUTIA INC. (ELUT) jointly with HighCape Partners GP II, LLC, HighCape Partners GP II, L.P., HighCape Partners QP II, L.P. | Gift (G): 70,000 @ $0 · Other (J): 50,000 @ $0 | EDGAR |
| 2026-05-20 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 251,185 (derivative) @ $0 | EDGAR |
| 2026-02-02 | 4 | ELUTIA INC. (ELUT) jointly with HighCape Partners GP II, LLC, HighCape Partners GP II, L.P., HighCape Partners QP II, L.P. | Purchase (P): 70,000 @ $1.06 | EDGAR |
| 2025-12-19 | 4/A | ELUTIA INC. (ELUT) jointly with HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HighCape Partners GP II, LLC, HighCape Partners GP II, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners QP II, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC | Other (J): 4,505,941 | EDGAR |
| 2025-12-19 | 4 | ELUTIA INC. (ELUT) jointly with HighCape Partners GP II, LLC, HighCape Partners GP II, L.P., HighCape Partners QP II, L.P. | Purchase (P): 50,000 @ $0.52 | EDGAR |
| 2025-12-17 | 4/A | ELUTIA INC. (ELUT) | Other (J): 4,505,941 | EDGAR |
| 2025-12-15 | 4 | ELUTIA INC. (ELUT) | Other (J): 4,372,497 | EDGAR |
| 2025-06-02 | 4 | ELUTIA INC. (ELUT) | Grant/award (A): 90,509 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 126,095 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | ELUTIA INC. (ELUT) jointly with HighCape Capital, L.P., Zuga Matt, HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Capital, LLC, HighCape Partners GP II, L.P., HighCape Co-Investment Vehicle I, LLC | Purchase (P): 420,000 @ $2.50 | EDGAR |
| 2024-08-01 | 4 | ELUTIA INC. (ELUT) jointly with HighCape Capital, L.P., Zuga Matt, HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners QP II, L.P., HighCape Partners GP II, LLC, HighCape Partners GP II, L.P. | Option exercise/expiry (X): 2,101,577 @ $1.43 · Option exercise/expiry (X): 2,101,577 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | ELUTIA INC. (ELUT) | Grant/award (A): 47,753 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 113,281 (derivative) @ $0 | EDGAR |
| 2024-01-08 | 4 | ELUTIA INC. (ELUT) jointly with HighCape Capital, L.P., Zuga Matt, HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners QP II, L.P., HighCape Partners GP II, LLC, HighCape Partners GP II, L.P. | Other (J): 1,436,077 · Other (J): 2,154,116 (derivative) | EDGAR |
| 2023-10-05 | 4 | ELUTIA INC. (ELUT) jointly with HighCape Capital, L.P., Zuga Matt, HighCape Partners GP, LLC, HighCape Partners GP, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners QP II, L.P., HighCape Partners GP II, LLC, HighCape Partners GP II, L.P. | Purchase (P): 2,837,128 · Purchase (P): 4,255,693 (derivative) | EDGAR |
| 2023-06-12 | 4 | AZIYO BIOLOGICS, INC. (AZYO) jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt | Grant/award (A): 37,500 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-05-16 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 120,481 (derivative) @ $0 | EDGAR |
| 2022-12-27 | 4 | AZIYO BIOLOGICS, INC. (AZYO) jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt | Grant/award (A): 17,533 (derivative) @ $0 | EDGAR |
| 2022-12-22 | 4 | Quantum-Si Inc (QSI) | Other (J): 601,000 @ $0 | EDGAR |
| 2022-12-16 | 4 | Quantum-Si Inc (QSI) | Sale (S): 89,000 @ $2.15 | EDGAR |
| 2022-12-07 | 4 | AZIYO BIOLOGICS, INC. (AZYO) jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt | Purchase (P): 735,000 @ $4.75 | EDGAR |
| 2022-06-09 | 4 | AZIYO BIOLOGICS, INC. (AZYO) jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt | Grant/award (A): 22,090 (derivative) @ $0 · Grant/award (A): 22,090 (derivative) @ $0 | EDGAR |
| 2022-05-13 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 59,880 (derivative) @ $0 | EDGAR |
| 2022-03-22 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Sale (S): 10,000 @ $9.41 | EDGAR |
| 2022-02-22 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Option exercise (M): 6,667 @ $4.80 · Tax withholding (F): 3,010 @ $10.63 · Option exercise (M): 6,667 (derivative) @ $0 | EDGAR |
| 2022-02-15 | 4/A | ORAMED PHARMACEUTICALS INC. (ORMP) | Gift (G): 5,000 @ $0 | EDGAR |
| 2022-02-14 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Gift (G): 5,000 @ $0 | EDGAR |
| 2022-01-05 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 6,000 · Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Gift (G): 5,000 @ $0 | EDGAR |
| 2021-12-10 | 4 | AZIYO BIOLOGICS, INC. (AZYO) jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt | Purchase (P): 353,773 @ $4.24 · Purchase (P): 58,962 @ $4.24 | EDGAR |
| 2021-09-20 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Sale (S): 21,100 @ $20.99 | EDGAR |
| 2021-09-02 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 10,000 | EDGAR |
| 2021-08-11 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Option exercise (M): 5,697 @ $6.23 · Tax withholding (F): 1,683 @ $21.09 · Option exercise (M): 6,666 @ $4.80 · Tax withholding (F): 1,517 @ $21.09 · Option exercise (M): 10,000 @ $4.17 · Tax withholding (F): 1,977 @ $21.09 · +6 more | EDGAR |
| 2021-06-15 | 4 | Quantum-Si Inc (QSI) | Grant/award (A): 1,901,000 @ $10 · Grant/award (A): 20,512 @ $0 | EDGAR |
| 2021-06-09 | 4 | AZIYO BIOLOGICS, INC. (AZYO) jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt | Grant/award (A): 14,082 (derivative) @ $0 · Grant/award (A): 14,082 (derivative) @ $0 | EDGAR |
| 2021-02-17 | 4 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2020-10-13 | 4 | AZIYO BIOLOGICS, INC. (AZYO) jointly with HighCape Capital, L.P., HIGHCAPE PARTNERS, L.P., HIGHCAPE PARTNERS QP, L.P., HighCape Partners GP, LLC, HighCape Partners GP, L.P., HighCape Co-Investment Vehicle I, LLC, HighCape Co-Investment Vehicle II, LLC, HighCape Capital, LLC, Zuga Matt | Conversion (C): 4,062,451 @ $0 · Option exercise/expiry (X): 7,655 @ $5.44 · Tax withholding (F): 2,451 @ $5.44 · Purchase (P): 441,176 @ $17 · Conversion (C): 31,133,977 (derivative) @ $0 · Option exercise/expiry (X): 7,655 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1184421 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs